Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback